| Date | Form | Description | Docs | XBRL | Pages |
| 01/16/24 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
46 |
| 01/04/23 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
40 |
| 01/04/22 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
63 |
| 01/07/21 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
77 |
| 01/10/20 | 10-K/A | Annual report pursuant to Section 13 and 15(d) |
|
110 | |
| 01/09/20 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
128 |
| 01/11/19 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
95 |
| 01/09/18 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
148 |
| 12/08/16 | 10-K/A | Annual report pursuant to Section 13 and 15(d) |
|
|
85 |
| 12/07/16 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
138 |
Latest News & Events
Anixa Biosciences to Present at the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10
Read More...Anixa Biosciences Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset
Read More...Anixa Biosciences Initiates Dosing in Third Cohort in its Ovarian Cancer CAR-T Clinical Trial
Read More...